NeuroSense Therapeutics

(NASDAQ) NRSN

Current Price$0.83

Market Cap$28.39M

Since IPO (2021)-80%

5 YearN/A

1 Year-16%

1 Month+9%

NeuroSense Therapeutics Financials at a Glance

Market Cap

$28.39M

Revenue (TTM)

$0.00

Net Income (TTM)

$8.66M

EPS (TTM)

$0.00

P/E Ratio

-1.37

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.83

Volume

201

Open

$0.83

Price

$0.83

Volume

201

Open

$0.83

Previous Close

$0.83

Daily Range

$0.83 - $0.83

52-Week Range

$0.63 - $2.60

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.83

Volume

201

Open

$0.83

Previous Close

$0.83

Daily Range

$0.83 - $0.83

52-Week Range

$0.63 - $2.60

NRSN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NeuroSense Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Alon Ben-Noon, MBA

Website

www.neurosense-tx.com

Headquarters

Herzliya, 4672562, IL

NRSN Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

Return on Assets

-6%

Earnings Yield

-72.99%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$28.39M

Shares Outstanding

35.35M

Volume

201

Avg. Volume

161.95K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$11.09M

EBITDA

$11.07M

Operating Cash Flow

$7.67M

Capital Expenditure

$8.00K

Free Cash Flow

$7.68M

Cash & ST Invst.

$166.00K

Total Debt

$170.00K

NeuroSense Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$28.39M

N/A

Market Cap/Employee

$1.67M

N/A

Employees

N/A

Net Income

$2.35M

-174.7%

EBITDA

$2.34M

+22.6%

Quarterly Fundamentals

Name

Q2 2025YOY CHG

Net Cash

$4.00K

-101.2%

Accounts Receivable

$33.00K

-91.9%

Inventory

$0.00

N/A

Long Term Debt

$72.00K

+278.9%

Short Term Debt

$98.00K

N/A

Return on Assets

-6.33%

N/A

Return on Invested Capital

4.34%

N/A

Free Cash Flow

$2.00K

N/A

Operating Cash Flow

$2.00K

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

XCURExicure, Inc.

XCURExicure, Inc.$3.36+1.51%

ENLVEnlivex Therapeutics Ltd.

ENLVEnlivex Therapeutics Ltd.$0.82+2.28%

TAOXTAO Synergies Inc.

TAOXTAO Synergies Inc.$5.13+6.21%

CVKDCadrenal Therapeutics, Inc. Common Stock

CVKDCadrenal Therapeutics, Inc. Common Stock$6.67+19.32%

NERVMinerva Neurosciences, Inc.

NERVMinerva Neurosciences, Inc.$6.47+1.25%

RLYBRallybio Corporation

RLYBRallybio Corporation$8.98+1.13%

SONNSonnet BioTherapeutics Holdings, Inc.

SONNSonnet BioTherapeutics Holdings, Inc.$1.26-59.35%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$94.48-0.00%

NOKNokia

NOKNokia$12.91+0.04%

AMZNAmazon

AMZNAmazon$265.06+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.10+0.04%

AAPLApple

AAPLApple$271.35+0.00%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.63+0.10%

MARAMara Holdings

MARAMara Holdings$11.99+0.12%

Questions About NRSN

What is the current price of NeuroSense Therapeutics?

NeuroSense Therapeutics is trading at $0.83 per share.

What is the 52-week range for NeuroSense Therapeutics?

Over the past 52 weeks, NeuroSense Therapeutics has traded between $0.63 and $2.60.

How much debt does NeuroSense Therapeutics have?

As of the most recent reporting period, NeuroSense Therapeutics reported total debt of $73,000.

How much cash does NeuroSense Therapeutics have on hand?

NeuroSense Therapeutics reported $3.41M in cash and cash equivalents in its most recent financial results.

What is NeuroSense Therapeutics’s dividend yield?

NeuroSense Therapeutics does not currently have a dividend yield.

NeuroSense Therapeutics

NeuroSense Therapeutics Financials at a Glance

NRSN News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About NeuroSense Therapeutics

NRSN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

NeuroSense Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NRSN

What is the current price of NeuroSense Therapeutics?

What is the 52-week range for NeuroSense Therapeutics?

How much debt does NeuroSense Therapeutics have?

How much cash does NeuroSense Therapeutics have on hand?

What is NeuroSense Therapeutics’s dividend yield?

Premium Investing Services